Respiratory player Vectura can set aside its hopes of snagging a new COPD indication for its combination med Flutiform--at least for now. Tuesday, the U.K. company sa...

Roche’s Tecentriq appeared on the immuno-oncology scene in May of this year, approved to treat bladder cancer and trailing Merck’s Keytruda and Bristol-Myers Squibb’s...

Amgen, Sanofi and Regeneron are awaiting much-anticipated outcomes data on their PCSK9 cholesterol-fighters--data payers and doctors see as key for adoption of the $1...